Sort
11,323 grants matching “glioblastoma”
Electrosonic Actuation Microarray: High-Throughput Tool for Transfection of Diffi
$486,274John Mark Meacham · Opencell Technologies, Inc. · R44 · FY2011 · RR
Efficacy of PDI inhibitors in glioblastoma
$486,251Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
Assaying GBM growth and therapy response in single cells and tumorspheres (PQ17)
$486,240Keith L Ligon · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model
$486,226David R Grosshans · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Metabolic and molecular regulation of myeloid cell functions in brain cancer
$486,185Filippo Veglia · Wistar Institute · R01 · FY2024 · NS
Efficacy of PDI inhibitors in glioblastoma
$486,120Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Efficacy of PDI inhibitors in glioblastoma
$486,120Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Identification of 9p and 20q Germline Alterations in Glioblastoma Pathogenesis
$486,065Robert B. Jenkins · Mayo Clinic Rochester · RC1 · FY2010 · NS
Radiation and Receptor Targeted RadioTheranostic Nanoparticles for Glioblastoma
$485,893Jay Fitzgerald Dorsey · University Of Pennsylvania · R01 · FY2015 · CA
Mechanisms of targeting cellular self-renewal in glioblastoma
$485,837Hatem Sabaawy · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA
Retroviral Coded Functions
$485,830Maxine L Linial · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Mechanisms of Chemo/Radioresistance in Human Gliomas
$485,801Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2005 · NS
Understanding EGF receptor activation by growth factors and oncogenic mutations
$485,609Mark A. Lemmon · Yale University · R01 · FY2016 · CA
Project 3: Targeting IDH mutant gliomas
$485,582Samuel Kent McBrayer · Brigham And Women'S Hospital · P50 · FY2024 · CA
Role of NKCC1 on Brain Tumor Stem Cell Migration After EGF and Slit-2 Stimulation
$485,447Alfredo Quinones-Hinojosa · Johns Hopkins University · R01 · FY2014 · NS
Proj. 2: Combining immune checkpoint blockade with T cell activation
$485,132E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2021 · CA
Identification and modeling of driver genetic modules in glioblastoma
$485,128Antonio Iavarone · Columbia University Health Sciences · R01 · FY2017 · CA
Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells
$485,104John H Sampson · Duke University · R01 · FY2014 · CA
Metabolic Control of Immune Suppression in Gliomas
$484,938Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2017 · NS
NRG Oncology NCORP Research Base-BIQSFP
$484,899Deborah W Bruner · Nrg Oncology Foundation, Inc. · UG1 · FY2025 · CA
Optimization of ultrasound-mediated drug delivery to the brain under clinically relevant conditions
$484,616Nathan J McDannold · Brigham And Women'S Hospital · R01 · FY2024 · EB
Development of Clinical Strategies to Prevent GBM Recurrences After Radiotherapy
$484,400John Martin Brown · Stanford University · R01 · FY2015 · CA
Physical Limits of Quantitative SPECT
$484,322Brigham And Women'S Hospital · R01 · FY2003 · EB
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
$484,305William R Roush · Scripps Florida · R01 · FY2014 · CA
Chromatin Modifications in GBM-Propagating Cells
$484,224John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2019 · NS